This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
(MedPage Today) -- Children and teens had an increased risk of being diagnosed with type 2 diabetes after COVID-19 infection, a retrospective cohort study of over 600,000 youth suggested. Adolescents 10 to 19 years old had a 55% higher risk for.
New York City-based NYU Langone hospital had the lowest 30-day mortality rate for heart attack patients in the U.S. between July 1, 2020 and June 30, 2023, according to CMS data released July 31.
Preeclampsia is a life-threatening pregnancy complication marked by persistent high blood pressure that is even more serious when it occurs early in the first trimester. The exact cause of early-onset preeclampsia is unknown, and it is difficult to predict, prevent and diagnose. Now researchers report on six proteins that could be used as targets to diagnose and treat the condition.
A study found that migraine-related disability worsens health-related quality of life, with gender-specific differences, particularly affecting women with mild disability.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Pregnant women with either low or excessively high levels of folate in their blood may face a greater risk of their children developing congenital heart disease, according to a study from Guangdong Provincial People's Hospital, China.
People who had a confirmed case of COVID-19 during the pandemic's first wave have twice the risk of heart attack, stroke and death compared to those who were never infected, according to research funded by the National Institutes of Health.
People who had a confirmed case of COVID-19 during the pandemic's first wave have twice the risk of heart attack, stroke and death compared to those who were never infected, according to research funded by the National Institutes of Health.
In this analysis, the investigators sought to assess the efficacy and safety of risankizumab compared to placebo for patients with palmoplantar psoriasis.
510(k) clearance secured from FDA allows for EIQ’s AI-enabled solution, EchoSolv AS, to be marketed and sold in the USA Clearance marks a major milestone and will allow for rapid commercial scale-up EIQ is in advanced discussions with a range of US healthcare providers around the potential uptake of EchoSolv AS Working alongside US consultancy to obtain reimbursement codes for the use of EchoSolv AS under insurance to scale up following FDA clearance Sydney: AI and Medical Technology company Ech
(MedPage Today) -- Non-laboratory-based risk factors and lipids measured in adolescence independently predicted adult cardiovascular events, according to data from seven longitudinal cohort studies. In a multivariable model using non-laboratory.
Circulation, Ahead of Print. Cardiac arrhythmias are commonly noted in patients during infections with and recovery from COVID-19. Arrhythmic manifestations span the spectrum of innocuous and benign to life-threatening and deadly. Various pathophysiological mechanisms have been proposed. Debate continues on the impact of incident and exacerbated arrhythmias on the acute and chronic (recovery) phase of the illness.
tim.hodson Mon, 10/14/2024 - 16:20 On Nov. 13, 2024, HIMSS will be presenting a webinar on "Addressing the Changing Data Demands of Next-Gen Healthcare." The webinar will take place at 1 p.m. Central time. The delivery of next-generation patient care relies upon seamless access to comprehensive and relevant patient data. However, the proliferation of patient data silos across multiple hosted environments can present significant integration challenges.
Does use of semaglutide decrease blood pressure (BP) and, if so, does it decrease it more in people with higher starting BPs? Also, can the BP drop be attributed solely to the weight loss?
In today’s fast-paced medical world, keeping up with the latest techniques and technologies is no longer a luxury for healthcare professionals it’s a necessity. This is where hands-on training programs come into play, serving as a critical component in the professional development of doctors across various specialties. At ADN Center of Excellence , we recognize that practical, experiential learning is vital for enhancing procedural expertise and improving patient outcomes.
The association between changes in insulin resistance, reflected by the triglyceride-glucose (TyG) index, and mortality remains unclear. This study investigated whether longitudinal trajectories of TyG index c.
Grand Blanc, Mich.-based McLaren Health Care has established the new McLaren Heart & Vascular Institute, unifying cardiology, vascular and cardiothoracic services across 13 of the health system's Michigan hospitals.
Patients with IBD or arthritis were not found to be at a significantly higher risk of serious infection with a biosimilar versus originator of the common drugs.
Special Edition: PharmD Appreciation: “PulseCheck†is a series within CardiaCast that is designed for Cardiovascular (CV) Team members who are new, or new to cardiology, offering practical team-based solutions to the everyday challenges.
The following are key points to remember from a systematic review and meta-analysis on the effects of catheter-based renal denervation in patients with hypertension (HTN).
The ustekinumab biosimilar will be available in early 2025, with indications to treat psoriasis, psoriatic arthritis, Crohn's disease and ulcerative colitis.
In today’s fast-paced medical world, keeping up with the latest techniques and technologies is no longer a luxury for healthcare professionals it’s a necessity. This is where hands-on training programs come into play, serving as a critical component in the professional development of doctors across various specialties. At ADN Center of Excellence , we recognize that practical, experiential learning is vital for enhancing procedural expertise and improving patient outcomes.
Cardiac tamponade is a critical cardiovascular condition where timely diagnosis and treatment are crucial. The formation of an intrapericardial hematoma following acupuncture therapy is clinically rare. This paper reports a case of an elderly female patient who experienced severe chest pain and syncope during acupuncture therapy, subsequently diagnosed with traumatic hemopericardium and acute cardiac tamponade, complicated by cardiogenic shock.
Background Heart failure (HF) is not included in atrial fibrillation (AF) bleeding risk prediction scores, reflecting uncertainty regarding its importance as a risk factor for major haemorrhage. We aimed to report the relative risk of first major haemorrhage in people with HF and AF compared with people with AF without HF (‘AF only’). Methods English primary care cohort study of 2 178 162 people aged ≥45 years in the Clinical Practice Research Datalink from January 2000 to Dece
BackgroundCoronary heart disease (CHD) is one of the leading causes of mortality. The current study aims to assess the association between C-reactive protein-triglyceride glucose index (CTI) and the risk of prevalent CHD and to evaluate the usefulness of CTI to refine the identification of prevalent CHD.Methods19,451 subjects from the National Health and Nutrition Examination Survey 1999–2010 were enrolled.
Objective Most patients who have an implantable cardioverter-defibrillator (ICD) implant do not receive life-prolonging therapy from it. Little research has been undertaken to determine which patients benefit the least from ICD therapy. As patients age and accumulate comorbidities, the risk of death increases and the benefit of ICDs diminishes. We sought to evaluate the impact of comorbidity, frailty, functional status on death with no prior appropriate ICD therapy.
Linaclotide was safe and effective for patients with chronic constipation and IBS with constipation who switched after non-response to magnesium oxide.
What is the efficacy and safety of different durations of dual antiplatelet therapy (DAPT) strategies in patients with acute coronary syndromes (ACS) using a Bayesian network meta-analysis?
Abstract Background The formation of transmural lesions is necessary for the ablation of persistent atrial fibrillation (prAF). Ablation index (AI) and generator impedance drop (ID) predict lesion size but their correlation with long-term outcomes in prAF is not known. Furthermore, we proposed a new parameter, efficacy ratio (ER) calculated as ID/AI, to gain indirect insight into the role of factors affecting ID but not considered by AI.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content